Rogobete on World Cancer Day: investments in screening, radiotherapy, new medicines, and robotic surgery for earlier cancer detection and treatment.
Romania joins the European CAPRICORD project to improve transparency in drug pricing and reimbursement decisions
Romania is participating in the European CAPRICORD project, funded through EU4Health, aimed at making decisions on drug pricing and reimbursement more transparent.
Romania’s Minister of Health, Alexandru Rogobete, announced the signing of a partnership agreement with the National Agency for Medicines and Medical Devices of Romania for the launch of the CAPRICORD project, a joint European initiative funded through the EU4Health programme, with the support of the European Commission via HADEA, and coordinated by NEAK Hungary.
The Romanian Ministry of Health is a beneficiary of the grant, which started this month and will run for a period of three years. According to the minister, the project aims to improve how decisions on drug pricing and reimbursement are made, through cooperation between authorities from 12 European countries.
“Decisions related to medicines are never abstract. They directly affect patients’ lives, families’ expectations, and the responsibility of physicians who must make difficult decisions every day in real-world clinical practice,” Alexandru Rogobete stated.
Through CAPRICORD, national authorities responsible for pricing and reimbursement will work together to enhance transparency and strengthen the public decision-making process. For patients, this means clearer rules, decisions that are easier to understand, and solutions better adapted to real medical needs.
The project also seeks to ensure that patients’ perspectives and healthcare professionals’ experience play a more significant role when deciding whether a medicine is reimbursed, under what conditions, and for which patients. At the same time, European cooperation provides national authorities with shared tools to better manage uncertainty, particularly in the case of innovative therapies and orphan drugs, where evidence is limited and budgetary pressure is high.
“For me, a good healthcare system is one that explains its decisions, takes responsibility for them, and remains connected to people’s real needs. CAPRICORD fits precisely into this framework,” the Minister of Health concluded.






